Elliot Norry - Net Worth and Insider Trading
Elliot Norry Net Worth
The estimated net worth of Elliot Norry is at least $10,965 dollars as of 2024-12-26. Elliot Norry is the Chief Medical Officer of Adaptimmune Therapeutics PLC and owns about 19,257 shares of Adaptimmune Therapeutics PLC (ADAP) stock worth over $10,965. Details can be seen in Elliot Norry's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Elliot Norry has not made any transactions after 2024-01-17 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Elliot Norry
Elliot Norry Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Elliot Norry owns 1 companies in total, including Adaptimmune Therapeutics PLC (ADAP) .
Click here to see the complete history of Elliot Norry’s form 4 insider trades.
Insider Ownership Summary of Elliot Norry
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ADAP | Adaptimmune Therapeutics PLC | 2024-01-17 | Chief Medical Officer |
Elliot Norry Latest Holdings Summary
Elliot Norry currently owns a total of 1 stock. Elliot Norry owns 19,257 shares of Adaptimmune Therapeutics PLC (ADAP) as of January 17, 2024, with a value of $10,965.
Latest Holdings of Elliot Norry
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ADAP | Adaptimmune Therapeutics PLC | 2024-01-17 | 19,257 | 0.57 | 10,965 |
Holding Weightings of Elliot Norry
Elliot Norry Form 4 Trading Tracker
According to the SEC Form 4 filings, Elliot Norry has made a total of 11 transactions in Adaptimmune Therapeutics PLC (ADAP) over the past 5 years, including 0 buys and 11 sells. The most-recent trade in Adaptimmune Therapeutics PLC is the sale of 20,563 shares on January 17, 2024, which brought Elliot Norry around $14,189.
Insider Trading History of Elliot Norry
- 1
Elliot Norry Trading Performance
Elliot Norry Ownership Network
Elliot Norry Owned Company Details
What does Adaptimmune Therapeutics PLC do?
Who are the key executives at Adaptimmune Therapeutics PLC?
Elliot Norry is the Chief Medical Officer of Adaptimmune Therapeutics PLC. Other key executives at Adaptimmune Therapeutics PLC include Chief Commercial Officer Cintia Piccina , Chief Operating Officer Bertrand William C Jr , and Chief Patient Supply Officer John Lunger .
Adaptimmune Therapeutics PLC (ADAP) Insider Trades Summary
Over the past 18 months, Elliot Norry made 2 insider transaction in Adaptimmune Therapeutics PLC (ADAP) with a net sale of 32,371. Other recent insider transactions involving Adaptimmune Therapeutics PLC (ADAP) include a net sale of 73,322 shares made by Adrian Rawcliffe , a net sale of 35,120 shares made by John Lunger , and a net sale of 32,818 shares made by Bertrand William C Jr .
In summary, during the past 3 months, insiders sold 0 shares of Adaptimmune Therapeutics PLC (ADAP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 245,864 shares of Adaptimmune Therapeutics PLC (ADAP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 245,864 shares.
Adaptimmune Therapeutics PLC (ADAP)'s detailed insider trading history can be found in Insider Trading Tracker table.
Adaptimmune Therapeutics PLC Insider Transactions
Elliot Norry Mailing Address
Above is the net worth, insider trading, and ownership report for Elliot Norry. You might contact Elliot Norry via mailing address: C/o Adaptimmune Therapeutics Plc, 60 Jubilee Ave, Milton Park, Abingdon, Oxfordshire X0 Ox14 4rx.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
